Detail akcie iSpecimen Rg online

Business Summary: iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, iSpecimen Inc revenues decreased 76% to $1.9M. Net loss decreased 15% to $5.5M. Revenues reflect Specimens – contracts with customers segment decrease of 77% to $1.7M, Shipping and other segment decrease of 39% to $133K. Lower net loss reflects Other income (expense) increase of 96% to $809K (income), Fulfillment - Balancing value decrease of 22% to $685K (expense).